Abstract
In order to determine the sites of net production and removal of the cyclic nucleotides in plasma, various blood vessels were catheterized in 17 anesthetized dogs and arterial and venous concentrations of adenosine 3′,5′-monophosphate (cAMP) and guanosine 3′,5′-monophosphate (cGMP) were measured by radioimmunoassay.
Aortic cAMP was 30±2 nM (mean±SE) and cGMP was 13±1 nM. There were no significant differences for either cyclic nucleotide between the concentration in the aorta and that in the inferior vena cava, coronary sinus, hepatic vein, and femoral vein. The concentration of cAMP in renal venous plasma was 25% lower than in aortic plasma, and renal venous cGMP was 51% lower than in the aorta. The pulmonary arterial concentrations of cAMP and cGMP were slightly lower than in the aorta. The concentration of cGMP in the superior mesenteric vein plasma was 83% greater than in aortic plasma; the concentration of cAMP in this vessel was only 16% greater than that in the aorta. Superior vena cava concentrations of both cyclic nucleotides were slightly greater than arterial concentrations.
The results suggest that: (a) the kidneys are a major site of removal of both cyclic nucleotides from plasma. (b) The lungs may be a site of net addition of both cyclic nucleotides to plasma. (c) The small intestine is a site of net production of both cyclic nucleotides, particularly cGMP. (d) The liver probably removes cyclic nucleotides from plasma. (e) Since no other organs or regions studied added detectable net amounts of cyclic nucleotides to plasma, and since the turnover of these compounds in plasma is known to be rapid, the production of plasma cyclic nucleotides under basal conditions may well be the result of small net contributions may well be the result of small net contributions from many tissues or bidirectional fluxes between tissues and plasma, or both.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ball J. H., Kaminsky N. I., Hardman J. G., Broadus A. E., Sutherland E. W., Liddle G. W. Effects of catecholamines and adrenergic-blocking agents on plasma and urinary cyclic nucleotides in man. J Clin Invest. 1972 Aug;51(8):2124–2129. doi: 10.1172/JCI107019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Blonde L., Wehmann R. E., Steiner A. L. Plasma clearance rates and renal clearance of 3H-labeled cyclic AMP and 3H-labeled cyclic GMP in the dog. J Clin Invest. 1974 Jan;53(1):163–172. doi: 10.1172/JCI107534. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Broadus A. E., Hardman J. G., Kaminsky N. I., Ball J. H., Sutherland E. W., Liddle G. W. Extracellular cyclic nucleotides. Ann N Y Acad Sci. 1971 Dec 30;185:50–66. doi: 10.1111/j.1749-6632.1971.tb45235.x. [DOI] [PubMed] [Google Scholar]
- Broadus A. E., Kaminsky N. I., Hardman J. G., Sutherland E. W., Liddle G. W. Kinetic parameters and renal clearances of plasma adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in man. J Clin Invest. 1970 Dec;49(12):2222–2236. doi: 10.1172/JCI106441. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Broadus A. E., Kaminsky N. I., Northcutt R. C., Hardman J. G., Sutherland E. W., Liddle G. W. Effects of glucagon on adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in human plasma and urine. J Clin Invest. 1970 Dec;49(12):2237–2245. doi: 10.1172/JCI106442. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chase L. R., Melson G. L., Aurbach G. D. Pseudohypoparathyroidism: defective excretion of 3',5'-AMP in response to parathyroid hormone. J Clin Invest. 1969 Oct;48(10):1832–1844. doi: 10.1172/JCI106149. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ishikawa E., Ishikawa S., Davis J. W., Sutherland E. W. Determination of guanosine 3',5'-monophosphate in tissues and of guanyl cyclase in rat intestine. J Biol Chem. 1969 Dec 10;244(23):6371–6376. [PubMed] [Google Scholar]
- Kaminsky N. I., Ball J. H., Broadus A. E., Hardman J. G., Sutherland E. W., Liddle G. W. Hormonal effects on extracellular cyclic nucleotides in man. Trans Assoc Am Physicians. 1970;83:235–244. [PubMed] [Google Scholar]
- Kaminsky N. I., Broadus A. E., Hardman J. G., Jones D. J., Jr, Ball J. H., Sutherland E. W., Liddle G. W. Effects of parathyroid hormone on plasma and urinary adenosine 3',5'-monophosphate in man. J Clin Invest. 1970 Dec;49(12):2387–2395. doi: 10.1172/JCI106458. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Murad F., Pak C. Y. Urinary excretion of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate. N Engl J Med. 1972 Jun 29;286(26):1382–1387. doi: 10.1056/NEJM197206292862604. [DOI] [PubMed] [Google Scholar]
- Steiner A. L., Parker C. W., Kipnis D. M. Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides. J Biol Chem. 1972 Feb 25;247(4):1106–1113. [PubMed] [Google Scholar]
- Taylor A. L., Davis B. B., Pawlson L. G., Josimovich J. B., Mintz D. H. Factors influencing the urinary excretion of 3',5'-adenosine monophosphate in humans. J Clin Endocrinol Metab. 1970 Mar;30(3):316–324. doi: 10.1210/jcem-30-3-316. [DOI] [PubMed] [Google Scholar]
- Wehmann R. E., Blonde L., Steiner A. L. Simultaneous radioimmunoassay for the measurement of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate. Endocrinology. 1972 Jan;90(1):330–335. doi: 10.1210/endo-90-1-330. [DOI] [PubMed] [Google Scholar]
- Zierler K. L. THEORY OF THE USE OF ARTERIOVENOUS CONCENTRATION DIFFERENCES FOR MEASURING METABOLISM IN STEADY AND NON-STEADY STATES. J Clin Invest. 1961 Dec;40(12):2111–2125. doi: 10.1172/JCI104437. [DOI] [PMC free article] [PubMed] [Google Scholar]